Search bioRxivSearch

EXPLORE THE ARCHIVE

Li, X.

Publications and source records attributed to Li, X..

3 recordsLinked to original sources

An M-learner approach for heterogeneous mediation analysis with high-dimensional omics mediators

Causal mediation analysis is widely used to identify biological pathways linking exposures to outcomes, but most methods assume homogeneous mediation effects across individuals. In high-dimensional omics settings, this assumption can mask important heterogeneity driven by demographic, genetic, or environmental factors. We propose the M-high-learner, a flexible framework for detecting heterogeneous mediation effects with high-dimensional mediators. The method identifies mediators with subgroup-specific indirect effects while distinguishing them from null or homogeneous signals and controlling the type I error rate. It is computationally efficient, scalable, and yields interpretable sub-types. Simulation studies show that the proposed approach achieves high power while maintaining accurate error control. Applications to the Framingham Heart Study and the Multi-Ethnic Study of Atherosclerosis reveal that the mediation role of gene expression in sexs effect on high-density lipoprotein varies across subgroups defined by body mass index and age. Our framework provides a practical tool for uncovering heterogeneous biological mechanisms in high-dimensional genomic studies. Author SummaryBiological processes linking risk factors to disease often differ across individuals, but many existing methods assume these processes are the same for everyone. This can hide important differences between groups. We developed a powerful method to identify when these pathways vary across subgroups using large-scale molecular data. Our approach detects differences in how intermediate biological factors contribute to outcomes in populations defined by characteristics such as age and body mass index. Applying our method to population studies, we found that some biological pathways operate differently across groups, suggesting that key mechanisms may be missed when differences are ignored. Our work provides a tool to better understand how disease-related processes vary across individuals, which may support more targeted and personalized approaches to health research.

bioinformatics

Dissecting the TMEM132A-EGFR Dependency to Unlock Translational Therapeutic Opportunities for Pan-Solid Tumor

Solid tumors remain refractory to conventional treatments, yet cell surface proteins, by virtue of their extracellular accessibility and critical roles in tumor signaling, represent an attractive class of targets for precision-targeted therapy. Here, we report that TMEM132A is an essential and previously unrecognized pan-cancer target. TMEM132A interacts directly with EGFR and stabilizes its expression, thereby tethering EGFR at the plasma membrane and sustaining constitutive activation of lipid synthesis. Mechanistically, the TMEM132A-EGFR axis promotes lipogenesis by facilitating SREBP nuclear translocation, which in turn upregulates ACLY and ACSS2 expression to drive acetyl-CoA production and downstream lipid biosynthesis, ultimately disrupting lipid droplet homeostasis. To therapeutically target this axis, we developed a nanobody, LFNanoT132A#3, which effectively blocks the TMEM132A-EGFR interaction, abrogates downstream signaling activation, and potently inhibits proliferation across multiple solid tumor types. Notably, LFNanoT132A also exerts robust antitumor activity against H1975 xenografts, a model resistant to first- and second- generation EGFR inhibitors, underscoring its potential to overcome conventional drug resistance. Our findings establish TMEM132A#3 as a critical node in membrane-tethered oncogenic signaling and metabolic rewiring, and position LFNanoT132A#3 as a promising therapeutic candidate for precision cancer therapy.

cancer biology

Near-infrared optoacoustic modulation of the blood-brain barrier permeability using size-tuned hyperbranched gold nanoconstructs

The blood-brain barrier (BBB) constitutes a major bottleneck for the systemic delivery of most therapeutic agents to the central nervous system. Here, we report near-infrared reversible optoacoustic modulation of the BBB permeability (NIR-ROAMBBB), leveraging endothelial tight junction targeting hyperbranched gold nanoconstructs (HBGNCs) to amplify localized optoacoustic transduction under femtosecond laser excitation. We first synthesized HBGNCs with tunable particle sizes (62-150 nm) and consistent branch morphologies via a seed-mediated growth approach, and uncovered a non-monotonic relationship between particle dimension and optoacoustic output, where the 62 nm HBGNCs generated nearly twofold stronger optoacoustic signal than gold nanorods and gold nanostars under matched excitations. Conjugation with BV11 antibodies against junctional adhesion molecule A increased HBGNC endothelial association and cerebral accumulation, enabling focal and fluence-dependent transient BBB opening (3-6 h) under 800 nm femtosecond pulsed laser excitation, as validated by in vitro trans-endothelial electrical resistance measurements, ex vivo Evans blue extravasation staining, and in vivo NIR imaging. Featuring deep tissue penetration of NIR light, robust optoacoustic conversion of HBGNCs, and negligible femtosecond laser-induced photothermal damage, this non-invasive strategy enables precise focal modulation of BBB permeability and potential drug delivery.

bioengineering